Psychiatr. pro Praxi, 2003; 1: 21-22

Psychofarmaka kardiologa a psychiatra nerozdělují

MUDr. Vladimír Lávička
Interní oddělení Nemocnice České Budějovice

Keywords: antipsychotics, antidepressants, ischaemic cardiac disease, depression, SSRI.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Lávička V. Psychofarmaka kardiologa a psychiatra nerozdělují. Psychiatr. praxi. 2003;4(1):21-22.

V běžné klinické praxi jsou pro kardiologa zajímavé zejména dvě skupiny psychofarmak, které hojně používá psychiatr. Anti­psychotika a antidepresiva. Antipsychotika z důvodu možných nežádoucích kardiovaskulárních účinků, některá antidepresiva naopak z možnosti zabránění závažných kardiovaskulárních příhod.

PSYCHOTHERAPEUTICS DO NOT DIVIDE A PSYCHIATRIST FROM A CARDIOLOGIST

In routine medical practice a cardiologist encounters mainly two groups of psychotherapeutics frequently used by a psychiatrist - antipsychotics and antidepressants. Antipsychotics can possibly cause unfavorable cardiac impacts, on the contrary some antidepressants can prevent major cardiovascular events.

Download citation

References

  1. Buckley NA. Cardiovascular Adverse effects of Antipsychotic Drugs, Drug Safety 2000; 23, 3: 215-228. Go to original source... Go to PubMed...
  2. Glassman AH, Roose SP, Bigger JT. The Safety of Tricyclic Antidepressants in Cardiac Patients. Risk-Benefit Reconsidered. JAMA. 1993; 269: 2673-2675. Go to original source... Go to PubMed...
  3. Glassman AH. Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina. JAMA.2002; 288: 701-709. Go to original source... Go to PubMed...
  4. Kölbel F. Trendy soudobé kardiologie 1999; 2: 35-40.
  5. Lane RM, Sweeney M, Henry JA. Pharmacoterapy of the depressed patient with cardiovascular and/or cerebrovascular illness. BJCP 1994; 48: 5. Go to original source...
  6. Musselman LD. The Relationship of Depression to Cardiovascular Disease. Epidemiology, Biology, and Treatment. Arch Gen Psychiatry. 1998; 55: 580-592. Go to original source... Go to PubMed...
  7. Pidrman V, Bouček J. Léčba depresí v ordinaci nepsychiatra. Lege artis 2001; 1: 5-7.
  8. Sheldon H.P., Clinical Pharmacology of Selective Serotonin Reuptake Inhibitors 1996; 1: 63-74.
  9. Šimon J. Deprese a úzkostné stavy zvyšují riziko kardiovaskulárních a interních chorob. Kapitoly z kardiologie 2000; 2: 86-88.
  10. Štejfa M. Kardiologie 1998; 2: 352-353.
  11. Švestka J. Psychofarmaka v klinické praxi 1995; 78-79.
  12. Topol EJ. Cardiovascular Medicine CD-ROM, Lippincott - Raven Publishers 1998.




Psychiatry for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.